People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...
Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...
Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...
AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Seniors on Medicare Part D will never pay more than $2,000 out-of-pocket for prescription drugs annually, thanks to a ...
More than 70,000 seniors in Washington state will save hundreds or thousands of dollars each year thanks to the new annual cap on out-of-pocket prescription drug costs for folks on Medicare Part D, ...
Medicare enrollees will now pay a maximum of $2,000 on out-of-pocket prescription drug costs annually as part of another ...
A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual ...
MA plans are substantially overpaid compared to traditional Medicare. Much of these overpayments benefit the MA plans rather ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
The Biden administration’s justification of the first cycle of Medicare drug price negotiations is fueling curiosity and ...
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included in the historic 2022 drug law ...